GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Heartware International, Inc. (FRA:HIY1) » Definitions » Cyclically Adjusted PS Ratio

Heartware International, (FRA:HIY1) Cyclically Adjusted PS Ratio : (As of Jun. 03, 2024)


View and export this data going back to . Start your Free Trial

What is Heartware International, Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Heartware International, Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Heartware International,'s Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heartware International, Cyclically Adjusted PS Ratio Chart

Heartware International, Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Heartware International, Quarterly Data
Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Heartware International,'s Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Heartware International,'s Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Heartware International,'s Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Heartware International,'s Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Heartware International,'s Cyclically Adjusted PS Ratio falls into.



Heartware International, Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Heartware International,'s Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2016 is calculated as:

For example, Heartware International,'s adjusted Revenue per Share data for the three months ended in Jun. 2016 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2016 (Change)*Current CPI (Jun. 2016)
=0.107/101.6881*101.6881
=0.107

Current CPI (Jun. 2016) = 101.6881.

Heartware International, Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
200609 0.000 85.606 0.000
200612 0.000 85.142 0.000
200703 0.000 86.640 0.000
200706 0.000 87.906 0.000
200709 0.000 87.964 0.000
200712 0.000 88.616 0.000
200803 0.000 90.090 0.000
200806 0.000 92.320 0.000
200809 0.000 92.307 0.000
200812 0.001 88.697 0.001
200903 0.004 89.744 0.005
200906 0.007 91.003 0.008
200909 0.015 91.120 0.017
200912 0.021 91.111 0.023
201003 0.017 91.821 0.019
201006 0.017 91.962 0.019
201009 0.022 92.162 0.024
201012 0.033 92.474 0.036
201103 0.026 94.283 0.028
201106 0.029 95.235 0.031
201109 0.032 95.727 0.034
201112 0.036 95.213 0.038
201203 0.040 96.783 0.042
201206 0.047 96.819 0.049
201209 0.036 97.633 0.037
201212 0.049 96.871 0.051
201303 0.073 98.209 0.076
201306 0.067 98.518 0.069
201309 0.072 98.790 0.074
201312 0.068 98.326 0.070
201403 0.084 99.695 0.086
201406 0.090 100.560 0.091
201409 0.093 100.428 0.094
201412 0.104 99.070 0.107
201503 0.113 99.621 0.115
201506 0.115 100.684 0.116
201509 0.101 100.392 0.102
201512 0.109 99.792 0.111
201603 0.086 100.470 0.087
201606 0.107 101.688 0.107

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Heartware International,  (FRA:HIY1) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Heartware International, Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Heartware International,'s Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Heartware International, (FRA:HIY1) Business Description

Traded in Other Exchanges
N/A
Address
Heartware International Inc was incorporated in Delaware on July 29, 2008 and became the successor issuer to HeartWare Limited, an Australian corporation, on November 13, 2008, as a result of the Australian Court approved redomiciliation of HeartWare Limited from Australia to Delaware. HeartWare is a medical device company engaged in developing implantable blood pumps for the treatment of advanced heart failure. The Company operates one reportable segment which includes the design, manufacture and marketing of medical devices for the treatment of advanced heart failure. The HeartWare Ventricular Assist System, which includes a left ventricular assist device, or blood pump, patient accessories and surgical tools, is designed to provide circulatory support for patients with advanced heart failure. Beyond the HeartWare System, the company is also evaluating its next device, the Miniaturized Ventricular Assist Device. The MVAD is based on the same technology platform as the HeartWare System but adopts an axial flow, rather than a centrifugal flow, configuration and is being developed in multiple configurations. The MVAD designs are currently at the preclinical stage and undergoing animal studies focused on minimally invasive implantation techniques and are each approximately one-third the size of the HVAD Pump. The Company's competitors in the implantable cardiac assist space include Thoratec Corporation, Jarvik Heart, Inc., MicroMed Cardiovascular, Berlin Heart GmbH, and Sunshine Heart, Inc. HEARTWARE, HVAD, MVAD, PAL, CIRCULITE, SYNERGY and various company logos are the trademarks of the Company, in the United States, Europe, Australia and other countries.

Heartware International, (FRA:HIY1) Headlines

No Headlines